| |
| |
|
| Insider
Information: |
Kelly James Patrick |
| Relationship: |
EVP, CFO and Treasurer |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
200,154 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$894,272 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
200,154 |
|
|
| Total
Value |
$894,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -19.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
EVP & Chief Financial ... |
2020-03-03 |
186,869 |
2011-08-29 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
EVP, CFO and Treasurer |
2024-03-10 |
13,285 |
2022-08-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2024-03-10 |
4 |
D |
$5.45 |
$12,132 |
D/D |
(2,226) |
13,285 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,608 |
15,511 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2024-03-07 |
4 |
D |
$5.61 |
$33,127 |
D/D |
(5,905) |
10,903 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2024-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,224 |
16,808 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2023-08-16 |
4 |
D |
$7.13 |
$8,150 |
D/D |
(1,143) |
4,584 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,366 |
5,727 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$16,111 |
D/D |
(2,471) |
3,361 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$30,051 |
D/D |
4,609 |
5,832 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,367 |
2,367 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CFO and Treasurer |
• – – |
2022-08-16 |
4 |
D |
$42.88 |
$49,055 |
D/D |
(1,144) |
1,223 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2020-03-03 |
4 |
S |
$10.76 |
$63,359 |
D/D |
(5,889) |
186,869 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2020-03-02 |
4 |
S |
$10.19 |
$132,087 |
D/D |
(12,968) |
192,758 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2020-01-02 |
4 |
S |
$15.94 |
$64,086 |
D/D |
(4,020) |
205,726 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2019-03-04 |
4 |
S |
$19.88 |
$173,961 |
D/D |
(8,751) |
209,746 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2019-03-01 |
4 |
S |
$20.15 |
$100,271 |
D/D |
(4,976) |
218,497 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
223,473 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2019-01-03 |
4 |
S |
$26.09 |
$42,232 |
D/D |
(1,619) |
193,473 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2019-01-02 |
4 |
S |
$26.31 |
$117,579 |
D/D |
(4,442) |
195,092 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2018-03-01 |
4 |
S |
$18.72 |
$159,712 |
D/D |
(8,532) |
199,534 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
208,066 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2018-01-02 |
4 |
S |
$15.35 |
$140,494 |
D/D |
(9,155) |
168,066 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
• – – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
177,221 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, CFO & Treasurer |
• – – |
2017-01-03 |
4 |
S |
$15.51 |
$169,013 |
D/D |
(10,895) |
69,721 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, CFO & Treasurer |
• – – |
2017-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,844 |
80,616 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP, CFO, Sec & Treasurer |
• – – |
2015-03-10 |
4 |
S |
$10.53 |
$131,099 |
D/D |
(12,450) |
53,304 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
